Chemistry Wealth Management’s Gotham 1000 Value ETF GVLU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.39M Buy
317,776
+17,136
+6% +$448K 1.34% 14
2026
Q1
$7.61M Buy
300,640
+9,354
+3% +$241K 1.34% 14
2025
Q4
$7.18M Buy
291,286
+10,694
+4% +$270K 1.34% 14
2025
Q3
$7.16M Buy
280,592
+4,994
+2% +$124K 1.38% 14
2025
Q2
$6.64M Buy
275,598
+10,947
+4% +$250K 1.42% 14
2025
Q1
$6.1M Buy
264,651
+20,638
+8% +$491K 1.42% 13
2024
Q4
$5.76M Buy
244,013
+29,003
+13% +$719K 1.35% 13
2024
Q3
$5.33M Buy
215,010
+20,082
+10% +$478K 1.26% 16
2024
Q2
$4.46M Buy
194,928
+47,968
+33% +$1.11M 1.15% 17
2024
Q1
$3.51M Buy
146,960
+41,394
+39% +$920K 0.94% 21
2023
Q4
$2.3M Buy
105,566
+25,287
+31% +$515K 0.7% 27
2023
Q3
$1.61M Buy
80,279
+57,496
+252% +$1.17M 0.53% 33
2023
Q2
$452K Buy
22,783
+2,833
+14% +$53.4K 0.15% 94
2023
Q1
$377K Buy
19,950
+8,089
+68% +$158K 0.13% 107
2022
Q4
$223K Buy
+11,861
New +$223K 0.09% 127

Other funds holding GVLU

Chemistry Wealth Management's GVLU Position: Q2 2026 in Review

Chemistry Wealth Management increased its Gotham 1000 Value ETF (GVLU) stake by 5.7% in Q2 2026, buying an estimated $448K and bringing the position to 317,776 shares worth $8.39M. The position accounts for 1.34% of the portfolio, ranked #14.

Chemistry Wealth Management first reported a position in GVLU in Q4 2022 and has held it in 15 quarters since. 5 funds tracked by Wall St. Rank hold GVLU as of Q2 2026.

  • Chemistry Wealth Management held 317,776 shares of Gotham 1000 Value ETF worth $8.39M as of Q2 2026.
  • Chemistry Wealth Management bought 17,136 Gotham 1000 Value ETF shares in Q2 2026, an estimated $448K.
  • Gotham 1000 Value ETF made up 1.34% of Chemistry Wealth Management's portfolio in Q2 2026, its #14 holding.
  • Chemistry Wealth Management first reported a position in Gotham 1000 Value ETF in Q4 2022 and has held it in 15 quarters since.
  • 5 funds tracked by Wall St. Rank held Gotham 1000 Value ETF as of Q2 2026.

Based on Chemistry Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.